1.Pediatric B-cell Lymphoma, Unclassifiable, With Intermediate Features Between Those of Diffuse Large B-cell Lymphoma and Burkitt Lymphoma: A Report of Two Cases.
Shanxiang ZHANG ; David WILSON ; Magdalena CZADER
Annals of Laboratory Medicine 2015;35(2):254-256
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Antineoplastic Combined Chemotherapy Protocols/therapeutic use
		                        			;
		                        		
		                        			Burkitt Lymphoma/*pathology
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			Cyclophosphamide/therapeutic use
		                        			;
		                        		
		                        			Doxorubicin/therapeutic use
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Gene Rearrangement
		                        			;
		                        		
		                        			Herpesvirus 4, Human/metabolism
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunohistochemistry
		                        			;
		                        		
		                        			Lymphoma, B-Cell/*diagnosis/drug therapy
		                        			;
		                        		
		                        			Lymphoma, Large B-Cell, Diffuse/*pathology
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Prednisone/therapeutic use
		                        			;
		                        		
		                        			Proto-Oncogene Proteins c-myc/genetics
		                        			;
		                        		
		                        			Tomography, X-Ray Computed
		                        			;
		                        		
		                        			Vincristine/therapeutic use
		                        			;
		                        		
		                        			Viral Matrix Proteins/immunology/metabolism
		                        			
		                        		
		                        	
2.Epstein-Barr virus latent genes.
Myung Soo KANG ; Elliott KIEFF
Experimental & Molecular Medicine 2015;47(1):e131-
		                        		
		                        			
		                        			Latent Epstein-Barr virus (EBV) infection has a substantial role in causing many human disorders. The persistence of these viral genomes in all malignant cells, yet with the expression of limited latent genes, is consistent with the notion that EBV latent genes are important for malignant cell growth. While the EBV-encoded nuclear antigen-1 (EBNA-1) and latent membrane protein-2A (LMP-2A) are critical, the EBNA-leader proteins, EBNA-2, EBNA-3A, EBNA-3C and LMP-1, are individually essential for in vitro transformation of primary B cells to lymphoblastoid cell lines. EBV-encoded RNAs and EBNA-3Bs are dispensable. In this review, the roles of EBV latent genes are summarized.
		                        		
		                        		
		                        		
		                        			Epstein-Barr Virus Infections/complications/virology
		                        			;
		                        		
		                        			Epstein-Barr Virus Nuclear Antigens/genetics/metabolism
		                        			;
		                        		
		                        			*Genes, Viral
		                        			;
		                        		
		                        			Herpesvirus 4, Human/*physiology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			MicroRNAs/genetics
		                        			;
		                        		
		                        			Neoplasms/etiology
		                        			;
		                        		
		                        			Protein Binding
		                        			;
		                        		
		                        			RNA, Viral/genetics
		                        			;
		                        		
		                        			Viral Matrix Proteins/genetics/metabolism
		                        			;
		                        		
		                        			*Virus Latency
		                        			
		                        		
		                        	
3.Comparison of Quantitation of Cytomegalovirus DNA by Real-Time PCR in Whole Blood with the Cytomegalovirus Antigenemia Assay.
Seonhee KWON ; Bo Kyeung JUNG ; Sun Young KO ; Chang Kyu LEE ; Yunjung CHO
Annals of Laboratory Medicine 2015;35(1):99-104
		                        		
		                        			
		                        			BACKGROUND: Quantitation of cytomegalovirus (CMV) DNA using real-time PCR has been utilized for monitoring CMV infection. However, the CMV antigenemia assay is still the 'gold standard' assay. There are only a few studies in Korea that compared the efficacy of use of real-time PCR for quantitation of CMV DNA in whole blood with the antigenemia assay, and most of these studies have been limited to transplant recipients. METHOD: 479 whole blood samples from 79 patients, falling under different disease groups, were tested by real-time CMV DNA PCR using the Q-CMV real-time complete kit (Nanogen Advanced Diagnostic S.r.L., Italy) and CMV antigenemia assay (CINA Kit, ArgeneBiosoft, France), and the results were compared. Repeatedly tested patients were selected and their charts were reviewed for ganciclovir therapy. RESULTS: The concordance rate of the two assays was 86.4% (Cohen's kappa coefficient value=0.659). Quantitative correlation between the two assays was a moderate (r=0.5504, P<0.0001). Among 20 patients tested repeatedly with the two assays, 13 patients were transplant recipients and treated with ganciclovir. Before treatment, CMV was detected earlier by real-time CMV DNA PCR than the antigenemia assay, with a median difference of 8 days. After treatment, the antigenemia assay achieved negative results earlier than real-time CMV DNA PCR with a median difference of 10.5 days. CONCLUSIONS: Q-CMV real-time complete kit is a useful tool for early detection of CMV infection in whole blood samples in transplant recipients.
		                        		
		                        		
		                        		
		                        			Antiviral Agents/therapeutic use
		                        			;
		                        		
		                        			Cytomegalovirus/*genetics
		                        			;
		                        		
		                        			Cytomegalovirus Infections/drug therapy/pathology/virology
		                        			;
		                        		
		                        			DNA, Viral/*blood/metabolism
		                        			;
		                        		
		                        			Ganciclovir/therapeutic use
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			*Immunoassay
		                        			;
		                        		
		                        			Organ Transplantation
		                        			;
		                        		
		                        			Phosphoproteins/genetics/immunology/*metabolism
		                        			;
		                        		
		                        			*Real-Time Polymerase Chain Reaction
		                        			;
		                        		
		                        			Viral Matrix Proteins/genetics/immunology/*metabolism
		                        			;
		                        		
		                        			Virology/*methods
		                        			
		                        		
		                        	
4.M gene analysis of canine coronavirus strains detected in Korea.
Seok Young JEOUNG ; So Yun ANN ; Hyun Tae KIM ; Doo KIM
Journal of Veterinary Science 2014;15(4):495-502
		                        		
		                        			
		                        			The purpose of this study was to investigate the genetic features of canine coronavirus (CCV) strains detected in Korea. M gene sequences obtained for isolates from 22 dogs with enteritis over a 5-year period were evaluated. Sequence comparison revealed that the 22 Korean CCV strains had an 87.2 to 100% nucleotide homology. Comparing to the typical reference CCV strains (type II), the nucleotide sequence of Korean strains had homology ranged from 86.3% to 98.3% (89.1% to 99.2% for the amino acid sequence) and 87.7% to 97.8% (92.4% to 100% for the amino acid sequence) when compared to FCoV-like CCV strains (type I). Three amino acid variations in the M gene were characteristic for the Korean CCV strains. Phylogenetic analysis demonstrated that the 22 Korean CCV strains belonged to four typical CCV clusters (i.e., a unique Korean CCV cluster, a type II and transmissible gastroenteritis virus cluster, an intermediate cluster between type I and II, and a type I cluster). This study was the first to identify genetic differences of the M gene from Korean CCV strains and provided a platform for molecular identification of different Korean CCV strains.
		                        		
		                        		
		                        		
		                        			Amino Acid Sequence
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Coronavirus Infections/epidemiology/*veterinary/virology
		                        			;
		                        		
		                        			Coronavirus, Canine/*isolation & purification
		                        			;
		                        		
		                        			Dog Diseases/*epidemiology/virology
		                        			;
		                        		
		                        			Dogs
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Molecular Sequence Data
		                        			;
		                        		
		                        			Phylogeny
		                        			;
		                        		
		                        			Polymerase Chain Reaction/veterinary
		                        			;
		                        		
		                        			Republic of Korea/epidemiology
		                        			;
		                        		
		                        			Reverse Transcriptase Polymerase Chain Reaction/veterinary
		                        			;
		                        		
		                        			Viral Matrix Proteins/*genetics/metabolism
		                        			
		                        		
		                        	
5.Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus.
Hai XU ; Yi-Wei WANG ; Ying-Hua TANG ; Qi-Sheng ZHENG ; Ji-Bo HOU
Chinese Journal of Virology 2013;29(4):376-381
		                        		
		                        			
		                        			To construct a recombinant T7 phage expressing matrix protein 2 ectodomain (M2e) peptides of avian influenza A virus and test immunological and protective efficacy in the immunized SPF chickens. M2e gene sequence was obtained from Genbank and two copies of M2e gene were artificially synthesised, the M2e gene was then cloned into the T7 select 415-1b phage in the multiple cloning sites to construct the recombinant phage T7-M2e. The positive recombinant phage was identified by PCR and sequencing, and the expression of surface fusion protein was confirmed by SDS-PAGE and Western-blot. SPF chickens were subcutaneously injected with 1 X 10(10) pfu phage T7-M2e, sera samples were collected pre- and post-vaccination, and were tested for anti-M2e antibody by ELISA. The binding capacity of serum to virus was also examined by indirect immunofluorescence assay in virus- infected CEF. The immunized chickens were challenged with 200 EID50 of H9 type avian influenza virus and viral isolation rate was calculated to evaluate the immune protective efficacy. A recombinant T7 phage was obtained displaying M2e peptides of avian influenza A virus, and the fusion protein had favorable immunoreactivity. All chickens developed a certain amount of anti-M2e antibody which could specially bind to the viral particles. In addition, the protection efficacy of phage T7-M2e vaccine against H9 type avian influenza viruses was 4/5 (80%). These results indicate that the recombinant T7 phage displaying M2e peptides of avian influenza A virus has a great potential to be developed into a novel vaccine for the prevention of avian influenza infection.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Antibodies, Viral
		                        			;
		                        		
		                        			blood
		                        			;
		                        		
		                        			Bacteriophage T7
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Chickens
		                        			;
		                        		
		                        			Enzyme-Linked Immunosorbent Assay
		                        			;
		                        		
		                        			Gene Expression Regulation, Viral
		                        			;
		                        		
		                        			Immunization
		                        			;
		                        		
		                        			Influenza A virus
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Influenza Vaccines
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Influenza in Birds
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			prevention & control
		                        			;
		                        		
		                        			Peptides
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Polymerase Chain Reaction
		                        			;
		                        		
		                        			Recombinant Fusion Proteins
		                        			;
		                        		
		                        			Specific Pathogen-Free Organisms
		                        			;
		                        		
		                        			Viral Matrix Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
6.The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists.
Yang YANG ; Ling ZHANG ; Heyuan GENG ; Yao DENG ; Baoying HUANG ; Yin GUO ; Zhengdong ZHAO ; Wenjie TAN
Protein & Cell 2013;4(12):951-961
		                        		
		                        			
		                        			The newly emerged Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic respiratory virus with pathogenic mechanisms that may be driven by innate immune pathways. The goal of this study is to characterize the expression of the structural (S, E, M, N) and accessory (ORF 3, ORF 4a, ORF 4b, ORF 5) proteins of MERS-CoV and to determine whether any of these proteins acts as an interferon antagonist. Individual structural and accessory protein-coding plasmids with an N-terminal HA tag were constructed and transiently transfected into cells, and their native expression and subcellular localization were assessed using Wes tern blotting and indirect immunofluorescence. While ORF 4b demonstrated majorly nuclear localization, all of the other proteins demonstrated cytoplasmic localization. In addition, for the first time, our experiments revealed that the M, ORF 4a, ORF 4b, and ORF 5 proteins are potent interferon antagonists. Further examination revealed that the ORF 4a protein of MERS-CoV has the most potential to counteract the antiviral effects of IFN via the inhibition of both the interferon production (IFN-β promoter activity, IRF-3/7 and NF-κB activation) and ISRE promoter element signaling pathways. Together, our results provide new insights into the function and pathogenic role of the structural and accessory proteins of MERS-CoV.
		                        		
		                        		
		                        		
		                        			Cell Line
		                        			;
		                        		
		                        			Coronavirus
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			pathogenicity
		                        			;
		                        		
		                        			Genes, Viral
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Interferons
		                        			;
		                        		
		                        			antagonists & inhibitors
		                        			;
		                        		
		                        			Open Reading Frames
		                        			;
		                        		
		                        			Recombinant Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Viral Matrix Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Viral Regulatory and Accessory Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Viral Structural Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
7.Establishment and characterization of a novel nasopharyngeal carcinoma cell line (SUNE2) from a Cantonese patient.
Ju-Qin DONG ; Man-Zhi LI ; Zhi-Gang LIU ; Qian ZHONG ; Dan XIONG ; Li-Hua XU ; Yong DU ; Yun-Fei XIA ; Mu-Sheng ZENG
Chinese Journal of Cancer 2012;31(1):36-44
		                        		
		                        			
		                        			The undifferentiated form of nasopharyngeal carcinoma (NPC) is the most common malignant head and neck cancer in South China, especially in Cantonese populations. However, few NPC cell lines have been established from the patients in this region. In this study, we established a new NPC cell line, termed SUNE2, from a Cantonese patient with undifferentiated NPC. This cell line had extremely low concentrations of Epstein-Barr virus (EBV) DNA in long-term culture and expressed low levels of latent membrane protein 1 (LMP1), latent membrane protein 2A (LMP2A), BamH1-A right frame 1 (BARF1), EBV-encoded RNA-1 (EBER1), and EBV-encoded RNA-2 (EBER2) in early passages. SUNE2 cells also showed much stronger transforming ability than 5-8F cells in colony formation assays and anchorage-independent growth assays in soft agar, and they only need 2 weeks to form tumors in nude mice. In summary, the SUNE2 cell line is a new in vitro model that can be used for further research on the mechanisms underlying the occurrence and development of NPC.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Asian Continental Ancestry Group
		                        			;
		                        		
		                        			Cell Line, Tumor
		                        			;
		                        		
		                        			Cell Transformation, Neoplastic
		                        			;
		                        		
		                        			Colony-Forming Units Assay
		                        			;
		                        		
		                        			DNA, Viral
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Herpesvirus 4, Human
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Inbred BALB C
		                        			;
		                        		
		                        			Mice, Nude
		                        			;
		                        		
		                        			Nasopharyngeal Neoplasms
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Neoplasm Transplantation
		                        			;
		                        		
		                        			RNA, Viral
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Viral Matrix Proteins
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Viral Proteins
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
8.Construction of recombinant baculovirus co-expressing M1 and HA of influenza A virus.
Peng-Wei XU ; Jian-Qiang GUO ; Li-Hong YAO ; Ai-Jun CHEN ; Xiao-Yu LIU ; Xian-Yin ZENG ; Zhi-Qing ZHANG
Chinese Journal of Virology 2012;28(3):231-236
		                        		
		                        			
		                        			The M1 and HA genes of H1N1 influenza virus were amplified and then cloned into the pFastBac dual donor plasmid. The recombinant pFastBac Dual-M1-HA was identified by restriction enzyme digestion. After the pFastBacdual-M1-HA was transformed into the baculovirus shuttle plasmid (bacmid) in DH10Bac competent cells, the colonies were identified by antibiotics and blue-white selection. The rBac-mid-M1-HA was verified by PCR and transfected into S f9 cells to produce recombinant baculovirus (rBac-M1-HA). Gene insertion of rBac-M1-HA was verified and the expression of M1 and HA genes was analyzed by IFA and Western-blot, demonstrating M1 and HA were co-expressed successfully. This study provides the foundation for researching the formation mechanism of influenza VLP and developing new influenza vaccines.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Baculoviridae
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Cell Line
		                        			;
		                        		
		                        			Cloning, Molecular
		                        			;
		                        		
		                        			Gene Expression
		                        			;
		                        		
		                        			Genetic Vectors
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Hemagglutinin Glycoproteins, Influenza Virus
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Influenza A Virus, H1N1 Subtype
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Spodoptera
		                        			;
		                        		
		                        			Transfection
		                        			;
		                        		
		                        			Viral Matrix Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			
		                        		
		                        	
9.Mechanism underlying the anterograde transport of the influenza A virus transmembrane proteins and genome in host cytoplasm.
Xiaojuan CHI ; Song WANG ; Yifan HUANG ; Jilong CHEN
Chinese Journal of Biotechnology 2012;28(9):1021-1030
		                        		
		                        			
		                        			Influenza virus assembly requires the completion of viral protein and vRNP transport to the assembly site at the plasma membrane. Therefore, efficient regulation of intracellular transport of the viral proteins and vRNPs to the surface of the host cell is especially important for virus morphogenesis. Influenza A virus uses the machineries of host cells to transport its own components including ribonucleoproteins (vRNPs) and three transmembrane proteins hemagglutinin (HA), neuraminidase (NA) and matrix 2 protein (M2). It has been shown that newly synthesized vRNPs are associated with active form of Rab11 and accumulate at recycling endosomes adjacent to the microtubule organizing center (MTOC) following nuclear export. Subsequently, they are transported along the microtubule network toward the plasma membranes in cargo vesicles. The viral transmembrane proteins are translated on the rough endoplasmic reticulum and transported to the virus assembly site at the plasma membrane. It has been found that several host factors such as ARHGAP21 and GTPase Cdc42 are involved in regulation of intracellular trafficking of influenza A virus transmembrane proteins including NA. In this review, we will highlight the current knowledge about anterograde transport and its regulation of the influenza A virus transmembrane proteins and genome in the host cytoplasm.
		                        		
		                        		
		                        		
		                        			Cytoplasm
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			GTP Phosphohydrolases
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			GTPase-Activating Proteins
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Genome, Viral
		                        			;
		                        		
		                        			Hemagglutinin Glycoproteins, Influenza Virus
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Influenza A virus
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			pathogenicity
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			Neuraminidase
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Protein Transport
		                        			;
		                        		
		                        			Ribonucleoproteins
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Viral Matrix Proteins
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			cdc42 GTP-Binding Protein
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
10.Role of Wnt5a and LMP1 in the nasopharyngeal carcinogenesis by high-throughput tissue microarray technology.
Lina XU ; Jun ZHENG ; Jiao LI ; Lei SHI ; Songqing FAN
Journal of Central South University(Medical Sciences) 2012;37(9):865-870
		                        		
		                        			OBJECTIVE:
		                        			To investigate the molecular mechanism of Wnt5a and Epstein-Barr virus latent membrane protein 1 (LMP1) aberrant expression in the nasopharyngeal carcinogenesis and to estimate if it can act as a molecular marker for nasopharyngeal cancer (NPC).
		                        		
		                        			METHODS:
		                        			Immunohistochemistry combined with previously made tissue microarrays were used to study the expression of Wnt5a and LMP1 in the nasopharyngeal carcinogenesis tissues. We investigated the role of over expression of Wnt5a and LMP1 in the development and progression of NPC and their relation with the clinicopathological features of NPC and whether they could act as molecular markers in benign and malignant NPC.
		                        		
		                        			RESULTS:
		                        			The positive percentage of Wnt5a and LMP1 protein expression in the NPC was significantly increased as compared with that in atypically hyperplastic nasopharyngeal epithelium, hyperplastic nasopharyngeal epithelium and histologically normal nasopharyngeal epithelium (P<0.05, P<0.01, and P<0.01). Wnt5a and LMP1 proteins were significantly higher in atypically hyperplastic nasopharyngeal epithelium than those in the hyperplastic nasopharyngeal epithelium and normal nasopharyngeal epithelium (P<0.05 and P<0.01). The positive expression of Wnt5a and LMP1 proteins in clinical T3 and T4 staged NPC was higher than that in clinical T1 and T2 staged NPC (P<0.01 and P<0.05). The positive expression of Wnt5a protein in the NPC with lymph node metastasis was higher than that in the NPC without lymph node metastasis (P<0.01). The positive percentage of LMP1 protein was significantly increased in non-keratinizing carcinoma compared with undifferentiated carcinoma and keratinizing carcinoma (P<0.05 and P<0.05). The expression of Wnt5a protein in the NPC had significant positive correlation with LMP1 (r=0.354, P<0.001). Combined molecular phenotype of both Wnt5a and LMP1 expression was a good marker to distinguish NPC from non-cancerous nasopharyngeal epithelium.
		                        		
		                        			CONCLUSION
		                        			The expression of Wnt5a and LMP1 protein in the NPC is positively correlated, and both wnt5a and LMP1 protein play important roles in the nasopharyngeal carcinogenesis either together or successively promoting the malignant transformation of nasopharyngeal epithelium and the development and progression of NPC. Both Wnt5a and LMP1 positive expression may act as good markers for NPC differential diagnosis.
		                        		
		                        		
		                        		
		                        			Biomarkers, Tumor
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Carcinogenesis
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Nasopharyngeal Neoplasms
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Oncogene Proteins, Viral
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Proto-Oncogene Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Tissue Array Analysis
		                        			;
		                        		
		                        			Viral Matrix Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Wnt Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Wnt-5a Protein
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail